Cysteine Market Size (US$ 516.3 Million) | Industry Report 2023-2028

IMARC Group, a leading market research company, has recently releases report titled "Cysteine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" The study provides a detailed analysis of the industry, including the global cysteine market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How big is the cysteine market?

The global cysteine market size reached US$ 387.5 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 516.3 Million by 2028, exhibiting a growth rate (CAGR) of 4.6% during 2023-2028.

What is a cysteine?

Cysteine refers to a non-essential sulfur-containing amino acid in humans found in beta-keratin, the main protein in skin, hair, and nails. It is manufactured through the hydrolysis of proteins in the presence of carbon dioxide. It is mainly used for protein synthesis, detoxification, and numerous metabolic functions. It is a component of the antioxidant glutathione and plays a crucial role in the metabolism of essential biochemicals, including coenzyme A, heparin, and biotin. It also helps reduce the risks of developing cancer, diabetes, and cardiovascular diseases (CVDs). Since it is a rich source of antioxidants, it assists in collagen production, improving skin elasticity and texture, reducing inflammation and cell damage, and reversing the signs of aging. Apart from this, cysteine is widely employed as a reducing agent in manufacturing pharmaceuticals, cosmetic and personal care products, food supplements, and flavor enhancers.

Request for a sample copy of this report: https://www.imarcgroup.com/cysteine-market/requestsample

What are the growth prospects and trends in the Cysteine industry?

The emerging product applications across various industries represent the primary factor driving market growth. For instance, in the pharmaceutical sector, cysteine is extensively utilized for total parenteral nutrition and as an antidote for acetaminophen overdose. Besides this, it also aids in treating metabolic disorders and malabsorption syndromes. In addition, there has been a rise in product usage in the food industry as a dough conditioner and strengthener to break the disulfide bonds of gluten and reduce the viscosity of dough in bakery products. Along with this, the increasing consumption of baked goods and the growing adoption of cysteine as a flavoring agent and nutritional supplement have augmented the product demand. Furthermore, there is an increase in the use of cysteine in cosmetics and personal care products as a fragrance ingredient and anti-static, conditioning, and waving agent in hair care products. In line with this, the surging product applications as a veterinary detoxicant and medication have catalyzed the market growth. Other factors, including the rapid expansion in the pharmaceutical sector, rising demand for plant-based cysteine products, the emerging trend of veganism, inflating consumer purchasing power, and ongoing research and development (R&D) activities, are also providing a positive thrust to the market growth. Looking forward, IMARC Group expects the market value to reach US$ 516.3 Million by 2028, growing at a CAGR of 4.6% during 2023-2028.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Production Process:

Natural
Synthetic

Breakup by Application:

Conditioner
Flavor Enhancer
Reducing Agent
Human Insulin Production
Others

Breakup by End-Use Industry:

Food
Pharmaceutical
Cosmetic
Animal Feed
Others

Breakup by Region:

North America (U.S. & Canada)
Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
Latin America (Brazil, Mexico)
Middle East & Africa

Who are the key players operating in the industry?

The report covers the major market players including:

Ajinomoto Co. Inc.
CJ CheilJedang Corp.
Merck KGaA
Nippon Rika Co. Ltd
Shanghai Cosroma Biotech Co. Ltd
Shine Star (Hubei) Biological Engineering Co. Ltd.
Wacker Chemie AG
Wuhan Grand Hoyo Co. Ltd. (Grand Pharma (China) Co. Ltd.)
Wuxi Bikang Bioengineering Co. Ltd.

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=4329&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.